Adverse outcome pathway (AOP): α2u-globulin nephropathy and kidney tumors in male rats.
Saved in:
| Title: | Adverse outcome pathway (AOP): α2u-globulin nephropathy and kidney tumors in male rats. |
|---|---|
| Authors: | Goyak KO; ExxonMobil Biomedical Sciences, Inc., Annandale, VA, USA., Sarang SS; Shell International, Shell Health, Houston, TX, USA., Franzen A; ToxStrategies, Inc., Monroe, LA, USA., Borghoff SJ; ToxStrategies, Inc., Cary, NC, USA., Ryman-Rasmussen JP; American Petroleum Institute, Washington, DC, USA. |
| Source: | Critical reviews in toxicology [Crit Rev Toxicol] 2022 May; Vol. 52 (5), pp. 345-357. Date of Electronic Publication: 2022 Jul 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914275 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1547-6898 (Electronic) Linking ISSN: 10408444 NLM ISO Abbreviation: Crit Rev Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1547-6898 |
|---|---|
| DOI: | 10.1080/10408444.2022.2082269 |
